Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Combination therapy for dyslipidemia: safety and regulatory considerations.
See All Pages
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
Return to Top
Combination therapy for dyslipidemia: safety and regulatory considerations.
Combination therapy for dyslipidemia: safety and regulatory considerations. Am J Cardiol. 2002 Nov 20; 90(10B):50K-60K.
View in:
PubMed
subject areas
Algorithms
Anticholesteremic Agents
Azetidines
Cholesterol, HDL
Cholesterol, LDL
Drug Therapy, Combination
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hyperlipidemias
Hypolipidemic Agents
Niacin
Safety